Monosodium Glutamate and Imidazole Propionate Production in Healthy Adults
This study is looking at whether monosodium glutamate (MSG), a common food flavor enhancer, affects the levels of a substance called imidazole propionate (ImP) in your blood. ImP is made by gut bacteria and has been linked to blood sugar control issues. Researchers want to see if taking MSG along with L-histidine (a dietary supplement) increases blood ImP levels compared to taking a salt placebo with L-histidine. They will also track how ImP levels change over time. You can join if you are a healthy adult, aged 18 or older, and have not used antibiotics recently. You cannot participate if you have diabetes, inflammatory bowel disease, an MSG allergy, or are pregnant or breastfeeding. The study plans to enroll 18 healthy volunteers.
- Study design
- This is an interventional study involving 18 healthy adult volunteers. Participants will receive L-histidine along with either monosodium glutamate or sodium chloride (salt) placebo.
- What's involved
- Participants will take L-histidine, 4 g/day, and either monosodium glutamate, 3 g/day, or sodium chloride, 940 mg/day, for 7 days during each treatment period.
- Compensation
- Not stated in the trial record.
- Follow-up
- Blood imidazole propionate concentration will be measured at Day 7 of each treatment period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Effect of Monosodium Glutamate on Microbiome-Derived Imidazole Propionate Production in Healthy Volunteers
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Difference in blood imidazole propionate concentration between the monosodium glutamate and sodium chloride treatment periodsDay 7 of each treatment period
Blood imidazole propionate concentration measured by liquid chromatography-mass spectrometry (LC-MS) from the blood sample collected on day 7 of each 7-day treatment period. The outcome is the within-participant difference between the day-7 concentration following the L-histidine + MSG period and the day-7 concentration following the L-histidine + NaCl period.